Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/08 → 3/31/10 |
A Phase 2, Open label trial to evaluate the Efficacy and Safety of MGCD0103 Administered in Combination with Vidaza to subjects with Relapsed or Refractory Hodgkins or non-Hodgkin Lymphoma and to evaluate different formulations of MGCD0103
- Hayslip, John (PI)